ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Immunoinformatics design of B and T-cell epitope-based SARS-CoV-2 peptide vaccination

Khan, Muhammad Shehzad; Khan, Ibrar Muhammad; Ahmad, Syed Umair; Rahman, Ishrat; Khan, Muhammad Zahoor; Khan, Muhammad Shah Zeb; Abbas, Zain; Noreen, Shumaila; Liu, Yong*中国农业大学; y
Frontiers in Immunology2023-1-4DOI: 10.3389/fimmu.2022.1001430
8阅读
引用收藏
分享

摘要

SARS-COV-2 is a virulent respiratory virus, first identified in China (Wuhan) at the end of 2019. Scientists and researchers are trying to find any possible solution to this deadly viral disease. Different drug source agents have been identified, including western medicine, natural products, and traditional Chinese medicine. They have the potential to counteract COVID-19. This virus immediately affects the liver and causes a decrease in oxygen levels. In this study, multiple vacciome approaches were employed for designing a multi-epitope subunit vaccine for battling against SARS-COV-2. Vaccine designing, immunogenicity, allergenic, and physico-chemical assessment were performed by using the vacciome approach. The vaccine design is likely to be antigenic and produce potent interactions with ACE2 and NSP3 receptors. The developed vaccine has also been given to in-silico cloning models and immune response predictions. A total number of 12 CTL and 12 HTL antigenic epitopes were predicted from three selected covid-19 virulent proteins (spike protein, nucleocapsid protein, and membrane proteins, respectively) based on C-terminal cleavage and MHC binding scores. These predicted epitopes were amalgamated by AYY and GPGPG linkers, and a beta-defensins adjuvant was inserted into the N-terminus of this vaccine. This analysis shows that the recommended vaccine can produce immune responses against SARS-COV-2. Designing and developing of the mentioned vaccine will require further experimental validation.

学科与关键词

关键词
SARS-CoV-2COVID-19vaccine designingvacciomedocking
相关
加载中…
  • Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis
    Yazdani, Zahra; Rafiei, Alireza*; Yazdani, Mohammadreza; Valadan, RezaInfection and Drug Resistance, 2020, 13: 3007-3022.被引 32
  • Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2
    Chakraborty, Chiranjib; Sharma, Ashish Ranjan; Bhattacharya, Manoji; Sharma, Garima; Lee, Sang-Soo*Archives of Medical Research, 2021, 52(4): 362-370.被引 26
  • Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach
    Abdelmageed, Miyssa I.; Abdelmoneim, Abdelrahman H.; Mustafa, Mujahed I.*; Elfadol, Nafisa M.; Murshed, Naseem S.; Shantier, Shaza W.; Makhawi, Abdelrafie M.Biomed Research International, 2020, 2020: 2683286.被引 108
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2023-01-04
卷期
第 13 卷
页码
1001430
DOI
10.3389/fimmu.2022.1001430
语言
ENGLISH
成果收录
SCIE
资助标注
Industry-University-Research Project of Fuyang Normal University [HX2021027000, HX2022048000]

作者

  • K

    Khan, Muhammad Shehzad (第一作者)

  • K

    Khan, Ibrar Muhammad

    fuyang normal univ

查看全部 9 位作者收起作者
  • A

    Ahmad, Syed Umair

  • R

    Rahman, Ishrat

  • K

    Khan, Muhammad Zahoor

    china agr univ

  • K

    Khan, Muhammad Shah Zeb

  • A

    Abbas, Zain

  • N

    Noreen, Shumaila

  • L

    Liu, Yong (通讯)

    fuyang normal univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417